Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
Ajouter des filtres








Gamme d'année
1.
Medisan ; 23(2)mar.-abr. 2019. ilus
Article Dans Espagnol | LILACS | ID: biblio-1002636

Résumé

Los digitálicos son fármacos con capacidad de aumentar la contractilidad miocárdica (inotrópico positivo), que han desempeñado un rol primordial en el tratamiento de pacientes con insuficiencia cardiaca; su uso inapropiado puede traer complicaciones serias a estos pacientes, incluso, hasta la muerte. La más importante de estas complicaciones es la intoxicación digitálica, originada por la sobredosis de dichos fármacos, a causa de la combinación del efecto inhibitorio en la conducción nodal y la estimulación sobre las fibras individuales auriculares y ventriculares. Debido al uso frecuente de estos medicamentos en todos los niveles de atención de salud y lo difícil que resulta diagnosticar dicha complicación por la complejidad de su cuadro clínico y de su expresión electrocardiográfica, se realizó una revisión bibliográfica exhaustiva sobre el tema para brindar amplia información, que permita una atención adecuada a los pacientes con este diagnóstico


Digitalis are drugs with the capacity of increasing myocardial contractility (inotropic positive agents) which have carried out an important role in the treatment of heart failure; their inappropriate use can bring severe complications to the patient, even, to death. The most important in these complications is the digitalis toxicity, originated by the overdose of these drugs, caused by the combination of the inhibitory effect in the nodal conduction and stimulation on the individual atrial and ventricular fibers. Due to the frequent use of these medications at all levels of medical care and to the difficulty in diagnosing this complication caused by the complexity of their clinical pattern and of their electrocardiographic expression, an exhaustive literature review was carried out on the topic to give a wide information that allows an appropriate care to the patients with this diagnosis


Sujets)
Humains , Mâle , Femelle , Glucosides digitaliques/intoxication , Glucosides digitaliques/pharmacologie , Effets secondaires indésirables des médicaments , Contraction myocardique/effets des médicaments et des substances chimiques , Intoxication , Mauvais usage des médicaments prescrits/métabolisme
2.
Rev. méd. Chile ; 146(11): 1309-1316, nov. 2018. tab, graf
Article Dans Espagnol | LILACS | ID: biblio-985704

Résumé

Acetylsalicylic acid (ASA) intoxication is potentially lethal. After ingestion, AAS is rapidly transformed into salicylic acid that dissociates into an hydrogen ion plus salicylate. Salicylate is the main form of AAS in the body and produces multiple alterations. Initially, the stimulation of the ventilatory center promotes a respiratory alkalosis. Then, the mitochondrial dysfunction induced by salicylate, will generate a progressive metabolic acidosis due to the accumulation of ketoacids, lactic acid and dicarboxylic acids among others. Another alterations include hydro electrolytic disorders, gastrointestinal lesions, neurological involvement, ototoxicity and coagulopathy. The correct handling of acetylsalicylic acid intoxication requires an thorough knowledge of its pharmacokinetics and pharmacodynamics. Treatment consists in life support measures, gastric lavage, activated charcoal and urinary alkalization to promote the excretion of salicylates. In some occasions, it will be necessary to start renal replacement therapy as soon as possible.


Sujets)
Humains , Acide acétylsalicylique/intoxication , Acide acétylsalicylique/métabolisme , Fibrinolytiques/intoxication , Fibrinolytiques/métabolisme , Mauvais usage des médicaments prescrits/physiopathologie , Mauvais usage des médicaments prescrits/thérapie , Acidose/induit chimiquement , Équilibre hydroélectrolytique/effets des médicaments et des substances chimiques , Acide acétylsalicylique/administration et posologie , Mauvais usage des médicaments prescrits/métabolisme , Hypoglycémie/induit chimiquement , Hypotension artérielle/induit chimiquement , Mitochondries/effets des médicaments et des substances chimiques
3.
Clinics ; 67(7): 821-826, July 2012. graf
Article Dans Anglais | LILACS | ID: lil-645457

Résumé

OBJECTIVE: The evaluation of S100B protein expression in the human heart and its correlation with drug-related death. METHOD: Left ventricular samples were collected from 74 serial forensic autopsies (15 overdose-related deaths; 59 non-overdose-related deaths) from 2007 to 2010. Tissue sections from each sample were immunostained for S100B protein by a commercial antibody. RESULTS: The S100B protein was detected in the heart samples of all 15 cases of drug-related deaths; S100B immunoreactivity was mainly observed in the cytoplasm of cardiomyocytes and as globular deposits in the interstitial spaces. No reactivity or weak reactivity was found in the cardiomyocytes of the 59 subjects who died of other causes. CONCLUSION: Our preliminary data show that the S100B protein accumulates in injured cardiomyocytes during drug-related sudden death. Given the near absence of S100B protein in the heart of subjects who died from causes other than drug overdose, S100B immunopositivity may be used as a new ancillary screening tool for the postmortem diagnosis of overdose-related cardiac death.


Sujets)
Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Enfant , Femelle , Humains , Mâle , Jeune adulte , Mauvais usage des médicaments prescrits/métabolisme , Myocarde/composition chimique , Facteurs de croissance nerveuse/métabolisme , /métabolisme , Autopsie , Marqueurs biologiques/analyse , Marqueurs biologiques/métabolisme , Cause de décès , Mauvais usage des médicaments prescrits/mortalité , Toxicologie médicolégale , Immunohistochimie , Facteurs de croissance nerveuse/analyse , /analyse
SÉLECTION CITATIONS
Détails de la recherche